Associations between socioeconomic status, atrial fibrillation, and outcomes: a systematic review

References

• Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110:1042–1046.
   PubMed Web of Science ®Google Scholar
• Chen LY, Shen WK. Epidemiology of atrial fibrillation: a current perspective. Hear Rhythm. 2007;4:S1-S6.
   Web of Science ®Google Scholar
• Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 2014;129:837–847.
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18:1609–1678.
   PubMed Web of Science ®Google Scholar
• Diug B, Evans S, Lowthian J, et al. The unrecognized psychosocial factors contributing to bleeding risk in warfarin therapy. Stroke. 2011;42:2866–2871.
   PubMed Web of Science ®Google Scholar
• Cohen N, Almoznino-Sarafian D, Alon I, et al. Warfarin for stroke prevention still underused in atrial fibrillation: patterns of omission. Stroke. 2000;31:1217–1222.
   PubMed Web of Science ®Google Scholar
• Zoni-Berisso M, Lercari F, Carazza T, et al. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol. 2014;6:213.
   PubMed Web of Science ®Google Scholar
• Thrall G, Lane D, Carroll D, et al. Quality of life in patients with atrial fibrillation: a systematic review. Am J Med. 2006;119:448 e1–19.
   PubMed Web of Science ®Google Scholar
• Lip GYH, Frison L, Halperin JL, et al. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (hypertension, abnormal renal/liver function, stroke, bleeding history or predisposition, labile INR, elderly, drug. J Am Coll Cardiol. 2011;57:173–180.
   PubMed Web of Science ®Google Scholar
• Pokorney SD, Simon DN, Thomas L, et al. Patients’ time in therapeutic range on warfarin among US patients with atrial fibrillation: results from ORBIT-AF registry. Am Heart J. 2015;170:141–148.e1.
   PubMed Web of Science ®Google Scholar
• Kaplan GA, Keil JE. Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation. 1993;88:1973–1998.
   PubMed Web of Science ®Google Scholar
• Suadicani P, Hein HO, Gyntelberg F. Socioeconomic status and ischaemic heart disease mortality in middle-aged men: importance of the duration of follow-up. The copenhagen male study. Int J Epidemiol. 2001;30:248–255.
   PubMed Web of Science ®Google Scholar
• Addo J, Ayerbe L, Mohan KM, et al. Socioeconomic status and stroke: an updated review. Stroke. 2012;43:1186–1191.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (reprinted from annals of internal medicine). Phys Ther. 2009;89:873–880.
   PubMed Web of Science ®Google Scholar
• Cochrane Bias Methods Group [Internet]. Tool to assess risk of bias in cohort studies. 2013 [cited 2017 Jan 10]. Available from: http://methods.cochrane.org
   Google Scholar
• Zöller B, Li X, Sundquist J, et al. Neighbourhood deprivation and hospitalization for atrial fibrillation in Sweden. Europace. 2013;15:1119–1127.
   PubMed Web of Science ®Google Scholar
• Misialek JR, Rose KM, Everson-Rose SA, et al. Socioeconomic status and the incidence of atrial fibrillation in whites and blacks: the Atherosclerosis Risk in Communities (ARIC) study. Jaha. 2014;3:e001159.
   Google Scholar
• Conen D, Buring JE, Everett BM, et al. Race/ethnicity but not socioeconomic status is a strong and independent risk factor for incident atrial fibrillation in women [abstract]. J Thromb Haemost. 2011;9:633–634.
   Web of Science ®Google Scholar
• Christensen AV, Koch MB, Davidsen M, et al. Educational inequality in cardiovascular disease depends on diagnosis: a nationwide register based study from Denmark. Eur J Prev Cardiol. 2015;23:826–833.
   Web of Science ®Google Scholar
• Shulman E, Kargoli F, Aagaard P, et al. Socioeconomic status and the development of atrial fibrillation in hispanics, African Americans and non-hispanic whites. Clin Cardiol. 2017;40:1–7.
   Web of Science ®Google Scholar
• Ramkumar S, Yang H, Wang Y, et al. Association between low socio-economic status and risk of incident atrial fibrillation [abstract]. Circulation. 2017;136:A14994.
   Web of Science ®Google Scholar
• Murphy NF, Simpson CR, Jhund PS, et al. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart. 2007;93:606–612.
   PubMed Web of Science ®Google Scholar
• Chien KL, Su TC, Hsu HC, et al. Atrial fibrillation prevalence, incidence and risk of stroke and all-cause death among Chinese. Int J Cardiol. 2010;139:173–180.
   PubMed Web of Science ®Google Scholar
• De Bacquer D, De Backer G, Kornitzer M. Prevalences of ECG findings in large population based samples of men and women. Heart. 2000;84:625–633.
   PubMed Web of Science ®Google Scholar
• Frewen J, Finucane C, Cronin H, et al. Factors that influence awareness and treatment of atrial fibrillation in older adults. Qjm. 2013;106:415–424.
   PubMed Web of Science ®Google Scholar
• Soliman EZ, Zhang Z, Judd S, et al. Comparison of risk of atrial fibrillation among employed versus unemployed (from the reasons for geographic and racial differences in stroke study). Am J Cardiol. 2007;120:1298–1301.
   Google Scholar
• Mattioli AV, Bonatti S, Zennaro M, et al. The relationship between personality, socio-economic factors, acute life stress and the development, spontaneous conversion and recurrences of acute lone atrial fibrillation. Europace. 2005;7:211–220.
   PubMed Web of Science ®Google Scholar
• Kupsky D, Wang DD, Eng M, et al. TCT-431 socioeconomic disparities in access for watchman device insertion in patients with atrial fibrillation and at elevated risk of bleeding [abstract]. J Am Coll Cardiol. 2017;70:B177.
   Web of Science ®Google Scholar
• Desai NR, Krumme AA, Schneeweiss S, et al. Patterns of initiation of oral anticoagulants in patients with atrial fibrillation - quality and cost implications. Am J Med. 2014;127:1075-1082.
   Web of Science ®Google Scholar
• Cressman AM, Macdonald EM, Yao Z, et al. Socioeconomic status and risk of hemorrhage during warfarin therapy for atrial fibrillation: a population-based study. Am Heart J. 2015;170:133–140.e3.
   PubMed Web of Science ®Google Scholar
• Wändell P, Carlsson AC, Gasevic D, et al. Neighbourhood socio-economic status and all-cause mortality in adults with atrial fibrillation: a cohort study of patients treated in primary care in Sweden. Int J Cardiol. 2016;202:776–781.
   PubMed Web of Science ®Google Scholar
• Kummer BR, Bhave PD, Merkler AE, et al. Demographic differences in catheter ablation after hospital presentation with symptomatic atrial fibrillation. J Am Heart Assoc. 2015;4:1–7.
   Web of Science ®Google Scholar
• Choudhry NK, Zagorski B, Avorn J, et al. Comparison of the impact of the atrial fibrillation follow-up investigation of rhythm management trial on prescribing patterns: a time-series analysis. Ann Pharmacother. 2008;42:1563–1572.
   PubMed Web of Science ®Google Scholar
• Hagengaard L, Søgaard P, Lytken Larsen M, et al. Lower educational level is associated with higher 1-year mortality after first hospitalization for atrial fibrillation and flutter - a nationwide register-based study [abstract]. Circulation. 2017;136:A16412.
   Web of Science ®Google Scholar
• Rodríguez-Bernal CL, Hurtado I, García-Sempere A. Oral anticoagulants initiation in patients with atrial fibrillation: real-world data from a population-based cohort. Front Pharmacol. 2017;8:1–8.
   PubMed Web of Science ®Google Scholar
• Vlacho B, Giner-Soriano M, Zabaleta-Del-Olmo E. Dabigatran and vitamin K antagonists ’ use in naïve patients with non-valvular atrial fibrillation : a cross-sectional study of primary care-based electronic health records. Eur J Clin Pharmacol. 2017;1323–1330.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Shiga T, Omori H. Adherence to medication and characteristics of Japanese patients with non-valvular atrial fibrillation. J Cardiol. 2017;70:238–243.
   PubMed Web of Science ®Google Scholar
• Dlott JS, George RA, Huang X, et al. National assessment of warfarin anticoagulation therapy for stroke prevention in atrial fibrillation. Circulation. 2014;129:1407–1414.
   PubMed Web of Science ®Google Scholar
• Steinberg BA, Holmes DN, Piccini JP, et al. Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation. J Am Heart Assoc. 2013;2:e000535.
   PubMed Web of Science ®Google Scholar
• Sholzberg M, Gomes T, Juurlink DN, et al. The influence of socioeconomic status on selection of anticoagulation for atrial fibrillation. PLoS One. 2016;11:e0149142.
   PubMed Web of Science ®Google Scholar
• Schauer DP, Moomaw CJ, Wess M, et al. Psychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarin. J Gen Intern Med. 2005;20:1114–1119.
   PubMed Web of Science ®Google Scholar
• Bernaitis N, Badrick T, Davey AK, et al. Quality of warfarin control in atrial fibrillation patients in South East Queensland, Australia. Intern Med J. 2016;46:925–931.
   PubMed Web of Science ®Google Scholar
• Al-Hijji MA, Deshmukh AJ, Yao X, et al. Trends and predictors of repeat catheter ablation for atrial fibrillation. Am Heart J. 2016;171:48–55.
   PubMed Web of Science ®Google Scholar
• Kargoli F, Shulman E, Aagaard P, et al. Arrhythmias and clinical EP socioeconomic status and predictors of survival in patients admitted with atrial fibrillation. J Am Coll Cardiol. 2015;65:A471.
   Web of Science ®Google Scholar
• Akerkar R, Ebbing M, Sulo G, et al. Educational inequalities in mortality of patients with atrial fibrillation in Norway. Scand Cardiovasc J. 2017;51:82–87.
   PubMed Web of Science ®Google Scholar
• Zimmerman EE, Ayres A, Gurol ME, et al. What factors determine choice of anticoagulant? [abstract]. Int Stroke Conf Poster Abstr. 2016;47:AWP415.
   Google Scholar
• Keshishian A, Du J, Xie L, et al. Demographic and socioeconomic characteristics that impact selection of oral anticoagulants among non-valvular atrial fibrillation patients. [abstract]. Value Heal.. 2016;19:A55.
   Web of Science ®Google Scholar
• Steinberg BA, Shrader P, Thomas L, et al. Factors associated with non – vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation : results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II). Am Heart J. 2017;189:40–47.
   PubMed Web of Science ®Google Scholar
• McCabe PJ, Schad S, Hampton A, et al. Knowledge and self-management behaviors of patients with recently detected atrial fibrillation. Heart Lung. 2008;37:79–90.
   PubMed Web of Science ®Google Scholar
• Reading SR, Go AS, Fang MC, et al. Health literacy and awareness of atrial fibrillation. J Am Heart Assoc. 2017;6:1–10.
   Web of Science ®Google Scholar
• Hernández Madrid A, Potpara TS, Dagres N, et al. Differences in attitude, education, and knowledge about oral anticoagulation therapy among patients with atrial fibrillation in Europe: result of a self-assessment patient survey conducted by the European heart rhythm association. Europace. 2016;18:463-467.
   Web of Science ®Google Scholar
• Lane D, Meyerhoff J, Roher U, et al. Effect of educational level on atrial fibrillation patients’ knowledge and perceptions about oral anticoagulation therapy : results from an international study [abstract]. Circulation. 2017;48:ATP294.
   Google Scholar
• Goli NM, Thompson T, Sears SF, et al. Educational attainment is associated with atrial fibrillation symptom severity. Pacing Clin Electrophysiol. 2012;35:1090–1096.
   PubMed Web of Science ®Google Scholar
• Ling LH, Hunter RJ, Bruggenjurgen B, et al. Sociodemographic and cardiovascular status but not anticoagulant choice independently predicts quality of life in patients with atrial fibrillation: results fromthe prefer in AF registry. Europace. 2014;16:iii17.
   Google Scholar
• Ball J, Carrington MJ, Stewart S. Mild cognitive impairment in high-risk patients with chronic atrial fibrillation: a forgotten component of clinical management? Heart. 2013;99:542–547.
   PubMed Web of Science ®Google Scholar
• Ertaş F, Kaya H, Atilgan ZA, et al. Predictors of warfarin use in patients with non-valvular atrial fibrillation who presented to the cardiology outpatient clinic of a tertiary hospital in Turkey: an observational study. Turkish J Med Sci. 2012;42:1172–1179.
   Web of Science ®Google Scholar
• Wändell P, Carlsson AC, Gasevic D, et al. Depression or anxiety and all-cause mortality in adults with atrial fibrillation – A cohort study in Swedish primary care. Ann Med. 2016;48:59–66.
   PubMed Web of Science ®Google Scholar
• Guhl EN, Althouse AD, Sharbaugh M, et al. Wealth brings health : annual income is associated with health-related quality of life in atrial fibrillation [abstract]. Circulation. 2017;136:A17217.
   Web of Science ®Google Scholar
• Doucet J, Gréboval-Furstenfeld E, Tavildari A, et al. Which parameters differ in very old patients with chronic atrial fibrillation treated by anticoagulant or aspirin? Antithrombotic treatment of atrial fibrillation in the elderly. Fundam Clin Pharmacol. 2008;22:569–574.
   PubMed Web of Science ®Google Scholar
• Carlsson AC, Wändell P, Gasevic D, et al. Neighborhood deprivation and warfarin, aspirin and statin prescription — A cohort study of men and women treated for atrial fibrillation in Swedish primary care. Int J Cardiol. 2015;187:547–552.
   PubMed Web of Science ®Google Scholar
• DeWilde S, Carey IM, Emmas C, et al. Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care. Heart. 2006;92:1064–1070.
   PubMed Web of Science ®Google Scholar
• Meschia JF, Merrill P, Soliman EZ, et al. Racial disparities in awareness and treatment of atrial fibrillation: the reasons for geographic and racial differences in stroke (REGARDS) study. Stroke. 2010;41:581–587.
   PubMed Web of Science ®Google Scholar
• Castellucci LA, Shaw J, Van der salm K, et al. Self-reported adherence to anticoagulation and its determinants using the Morisky medication adherence scale. Thromb Res. 2015;136:727–731.
   PubMed Web of Science ®Google Scholar
• Ba Ö, Dogan V, Biteker M, et al. Guideline-adherent therapy for stroke prevention in atrial fi brillation in different health care settings : results from RAMSES study collaborators. Eur J Intern Med. 2017;40:50–55.
   PubMedGoogle Scholar
• Moreno-Arribas J, Bertomeu-González V, Anguita-Sanchez M, et al. Choice of new oral anticoagulant agents versus vitamin K antagonists in atrial fibrillation: FANTASIIA study. J Cardiovasc Pharmacol Ther. 2016;21:150–156.
   PubMed Web of Science ®Google Scholar
• Lam CSP. The socioeconomics of hypertension: how $50 000 may buy a drop in blood pressure. Hypertension. 2011;58:140–141.
   PubMedGoogle Scholar
• van Oers JA, Bongers IM, van de Goor LA, et al. Alcohol consumption, alcohol-related problems, problem drinking, and socioeconomic status. Alcohol Alcohol. 1999;34:78–88.
   PubMed Web of Science ®Google Scholar
• Adler NE, Newman K. Socioeconomic disparities in health: pathways and policies. Health Aff. 2002;21:60–76.
   PubMed Web of Science ®Google Scholar
• Perkins JM, Subramanian SV, Smith GD, et al. Adult height, nutrition, and population health. Nutr Rev. 2016;74:149–165.
   PubMed Web of Science ®Google Scholar
• Rosengren A, Hauptman PJ, Lappas G, et al. Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men. Eur Heart J. 2009;30:1113–1120.
   PubMed Web of Science ®Google Scholar
• Galobardes B, Shaw M, Lawlor DA, et al. Indicators of socioeconomic position (part 1). J Epidemiol Community Health. 2006;60:7–12.
   PubMed Web of Science ®Google Scholar
• Ridic G, Gleason S, Ridic O. Comparisons of health care systems in the United States, Germany and Canada. Mater Sociomed. 2012;24:112–120.
   PubMedGoogle Scholar
• Bidgood E Healthcare systems: Sweden & localism – an example for the UK? [online report] [Internet]. Online report for Institute for the Study of Civil Society (Civitas); 2013
   Google Scholar
• Veugelers PJ, Yip AM. Socioeconomic disparities in health care use: does universal coverage reduce inequalities in health? J Epidemiol Community Health. 2003;57:424–428.
   PubMed Web of Science ®Google Scholar
• Lip GYH, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137:263–272.
   PubMed Web of Science ®Google Scholar
• Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139–1151.
   PubMed Web of Science ®Google Scholar
• Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883–891.
   Google Scholar
• Granger CB, Alexander JH, McMurray JJV, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981–992.
   PubMed Web of Science ®Google Scholar
• Raparelli V, Proietti M, Buttà C, et al. Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study. Intern Emerg Med. 2014;9:861–870.
   PubMed Web of Science ®Google Scholar
• Singh SM, Webster L, Ko DT, et al. Factors associated with cardiac electrophysiologist assessment and catheter ablation procedures in patients with atrial fibrillation. JACC Clin Electrophysiol. 2017;3:302–309.
   PubMedGoogle Scholar
• Ranstad K, Midlöv P, Halling A. Socioeconomic status and geographical factors associated with active listing in primary care: a cross-sectional population study accounting for multimorbidity, age, sex and primary care. BMJ Open 2017;7:1–11.
   Web of Science ®Google Scholar
• Stuckler D, Feigl AB, Basu S, et al. The political economy of universal health coverage. [Backround paper for the First Global Symposium on Health Systems Research] Montreux, Switzerland: World Health Organization; 2010.
   Google Scholar
• Higgins J, Green S Cochrane handbook for systematic reviews of interventions version 5.1.0 [Internet]. The Cochrane Collaboration; 2011 [updated March 2011].
   Google Scholar
• Blaauw Y, Crijns HJGM. Atrial fibrillation: insights from clinical trials and novel treatment options. J Intern Med. 2007;262:593–614.
   PubMed Web of Science ®Google Scholar
• Krieger N, Chen JT, Waterman PD, et al. Choosing area based socioeconomic measures to monitor social inequalities in low birth weight and childhood lead poisoning: the public health disparities geocoding project (US). J Epidemiol Community Health. 2003;57:186–199.
   PubMed Web of Science ®Google Scholar
• Demissie K, Hanley JA, Menzies D, et al. Agreement in measuring socio-economic status: area-based versus individual measures. Chronic Dis Can. 2000;21:1–7.
   PubMedGoogle Scholar
• Subramanian SV, Chen JT, Rehkopf DH, et al. Comparing individual- and area-based socioeconomic measures for the surveillance of health disparities: a multilevel analysis of Massachusetts births, 1989–1991. Am J Epidemiol. 2006;164:823–834.
   PubMed Web of Science ®Google Scholar